Literature DB >> 24277708

Medical abortion in Canada: behind the times.

Sheila Dunn, Rebecca Cook.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24277708      PMCID： PMC3883814          DOI： 10.1503/cmaj.131320

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden.

Authors:  Rachel K Jones; Stanley K Henshaw
Journal:  Perspect Sex Reprod Health       Date:  2002 May-Jun

2.  Induced abortion in Canada 1974-2005: trends over the first generation with legal access.

Authors:  Wendy V Norman
Journal:  Contraception       Date:  2011-08-04       Impact factor: 3.375

Review 3.  Medication abortion in Canada: a right-to-health perspective.

Authors:  Joanna N Erdman; Amy Grenon; Leigh Harrison-Wilson
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

Review 4.  First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.

Authors:  Elizabeth G Raymond; Caitlin Shannon; Mark A Weaver; Beverly Winikoff
Journal:  Contraception       Date:  2012-08-13       Impact factor: 3.375

5.  Mifepristone.

Authors: 
Journal:  J Obstet Gynaecol Can       Date:  2009-12

6.  Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol.

Authors:  Ellen Wiebe; Sheila Dunn; Edith Guilbert; Francis Jacot; Lisa Lugtig
Journal:  Obstet Gynecol       Date:  2002-05       Impact factor: 7.661

7.  Canadian access to hormonal contraceptive drug choices.

Authors:  Dianne Azzarello; John Collins
Journal:  J Obstet Gynaecol Can       Date:  2004-05

8.  Barriers to rural induced abortion services in Canada: findings of the British Columbia Abortion Providers Survey (BCAPS).

Authors:  Wendy V Norman; Judith A Soon; Nanamma Maughn; Jennifer Dressler
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240
  8 in total
  5 in total

1.  Abortion remains absent from family medicine training in Canada.

Authors:  Daniel Myran; Jillian Bardsley
Journal:  Can Fam Physician       Date:  2018-08       Impact factor: 3.275

2. 

Authors:  Daniel Myran; Jillian Bardsley
Journal:  Can Fam Physician       Date:  2018-08       Impact factor: 3.275

3.  Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study.

Authors:  Sarah Munro; Edith Guilbert; Marie-Soleil Wagner; Elizabeth S Wilcox; Courtney Devane; Sheila Dunn; Melissa Brooks; Judith A Soon; Megan Mills; Genevieve Leduc-Robert; Kate Wahl; Erik Zannier; Wendy V Norman
Journal:  Ann Fam Med       Date:  2020-09       Impact factor: 5.166

4.  Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.

Authors:  Wendy V Norman; Sarah Munro; Melissa Brooks; Courtney Devane; Edith Guilbert; Regina Renner; Tamil Kendall; Judith A Soon; Ashley Waddington; Marie-Soleil Wagner; Sheila Dunn
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

5.  Feasibility and Acceptability of a Mobile Technology Intervention to Support Postabortion Care in British Columbia: Phase I.

Authors:  Roopan Gill; Gina Ogilvie; Wendy V Norman; Brian Fitzsimmons; Ciana Maher; Regina Renner
Journal:  J Med Internet Res       Date:  2019-05-29       Impact factor: 5.428
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.